Kinase inhibitor and use thereof
US9949976B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Sep 14, 2017 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Sep 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5386
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a CDK4/6 kinase inhibitor, or a pharmaceutically acceptable salt, ester, or solvate thereof, or their isomers; a pharmaceutical formulation, pharmaceutical composition and kit comprising said CDK4/6 kinase inhibitor, or a pharmaceutically acceptable salt, ester, or solvate thereof, or their isomers, and use of said CDK4/6 kinase inhibitor, or a pharmaceutically acceptable salt, ester, or solvate thereof, or their isomers. For example, the compounds of the invention are useful for reducing or inhibiting the activity of CDK4/6 kinase in a cell, and/or treating and/or preventing a cancer-related disease mediated by CDK4/6 kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.